Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.
Clinical trial NCT03589313 · COMPLETED
Trial details
- NCT number
- NCT03589313
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2018-03-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.